Agilis Robotics Closes $10M Series A+ Financing for Flexible Medical Robotics

Agilis Robotics, a Hong Kong-based medical robotics startup, has closed US$10 million Series A+ financing from a Singaporean family fund to advance the research and development and clinical registrations of its fully flexible robotic instruments, bringing its total funding to $17 million over three rounds.

Agilis Robotics was founded in 2021 by several founders, including Kwok Ka-Wai, currently Associate Professor in the Department of Mechanical Engineering at the University of Hong Kong, and Jason Y K Chan, currently Assistant Professor in the Department of Otorhinolaryngology, Head and Neck Surgery at the Chinese University of Hong Kong, with a focus on fully flexible robotic instruments for endoluminal surgery with cutting edge mechanical architecture.

The robotic system can be seamlessly integrated into current clinical workflows and dramatically reduces the learning curve associated with endoscopic surgery. The fully flexible robotic arm allows the surgeon to effectively remove all tumour tissue, particularly in early stage gastrointestinal and urinary tract cancers.

Agilis Robotics has already initiated clinical cooperation with many top hospitals and will continue to strengthen cooperation with medical teams at home and abroad, actively expand the overseas cooperation circle, and simultaneously open the global product registration programme.

Agilis Robotics’ fully flexible endoscopic surgical robots have entered the registration and approval process with the US FDA and China’s National Medical Products Administration (NMPA). Agilis Robotics has also set up subsidiaries in Hong Kong (China), Guangzhou/Shenzhen (China), and Boston (USA), and is actively preparing to establish manufacturing bases and training centers.

en_GBEnglish (UK)